CD40 and the effect of anti-CD40-binding on human multiple myeloma clonogenicity

Leukemia and Lymphoma

Volumn 21, Issue 1-2, 1996, Pages 1-8

  Tong, Alex W ^a   Stone, Marvin J ^a  

^a BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Adhesion molecules; CD40; gp39; Interleukin 6 clonogenic colony formation; Multiple myeloma

Indexed keywords

B LYMPHOCYTE ANTIGEN; CD40 ANTIGEN; IMMUNOGLOBULIN E; INTERLEUKIN 6; LIGAND; LYMPHOCYTE ANTIGEN RECEPTOR; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1;

ANTIGEN BINDING; B LYMPHOCYTE; BONE MARROW CELL; CELL CYCLE; CELL PROLIFERATION; CLONOGENESIS; HUMAN; IMMUNOGLOBULIN PRODUCTION; LYMPHOCYTE ACTIVATION; MULTIPLE MYELOMA; MYELOMA CELL; PLASMA CELL DYSCRASIA; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

EID: 0030028979     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199609067572     Document Type: Review

References (83)

1. Stone, M. J. (1982) Monoclonal gammopathies: Clinical Aspects, in Ritzmann SE (ed): Pathology of Immunoglobulins: Diagnostic and Clinical Aspects. Protein Abnormalities. Vol 2. New York, NY, Liss, p 161.
2. Klein, B. and Bataille, R. (1992) Cytokine network in human multiple myeloma. Hematol. Oncol. Clin. N. America, 6, 273.
3. Moscinski, L. C. and Ballester, O. F. (1994) Recent progress in multiple myeloma. Hematol. Oncol., 12, 111.
4. Mandelli, F., Avisati, G. and Tribalto, M. (1992) Biology and treatment of multiple myeloma. Current Opin. Oncol., 4, 73.
5. Tong, A. W., Hanson, T., Zhang, B. and Stone, M. J. (1992) Stimulation of human multiple myeloma clonogenic colonies by a monoclonal antibody to the B lineage antigen CD40 (Abstract). Blood, 80 (Suppl 1), 124a.
6. Gordon, J., Katira, A., Holder, M., MacDonald, I. and Pound, J. (1994) Central role of CD40 and its ligand in B lymphcyte responses to T-dependent antigens. Cell Mol. Biol., 40 (Suppl I), 1.
7. Hollenbaugh, D., Ochs, H. D., Noelle, R. J., Ledbetter, J. A. and Aruffo, A. (1994) The role of CD40 and its ligand in the regulation of the immune response, Immunol. Rev., 138, 23.
8. Liu, Y, J., Joshua, D, E., Williams, G. T., Smith, C. A., Gordon, J. and MacLennan I. C. M. (1989) Mechanism of antigen-drive selection in germinal centres. Nature, 342, 929.
9. Splawski, J. B., Fu, S. M. and Lipsky, P. E. (1993) Immunoregulatory role of CD40 in human B cell differentiation. J. Immunol., 150, 1276.
10. Clark, E. A. and Shu, G. (1990) Association between IL-6 and CD40 signaling. IL-6 induces phosphorylation of CD40 receptors. J. Immunol., 145, 1400.
11. Klein, B., Zhang, X. G., Lu, Z. Y. and Bataille, R. (1995) Interleukin-6 in human multiple myeloma. Blood, 85, 863.
12. Tong, A. W., Zhang, B. Q., Mues, G., Solano, M., Hanson, T. and Stone, M. J. (1994) Anti-CD40 antibody binding modulates human multiple myeloma clonogenicity in vitro. Blood, 84, 3026.
13. Weslendorf, J. J., Ahmann, G. A., Armitage, R. J., Spriggs, M, K., Lust, J. A., Greipp, P. R., Katzmann, J. A. and Jelinek, D. F. (1994) CD40 expression in malignant plasma cells. Role in stimulation of autocrine IL-6 secretion by a human myeloma cell line. J. Immunol., 152, 117.
14. Bakkus, M. H. C., Riet, I. V., De Greef, C., de Boer, M., Thielemans, K. and Van Camp, B. (1993) Expression of activation molecules (CD40, B7 and CD28) in human multiple myeloma, Proc IV Intl Workshop on Multiple Myeloma Pp 127, Mayo Medical Center: Rochester.
15. Pellat-Deceunynck, C., Bataille, R., Robillard, N., Harousseau, J. L., Rapp, M. J., Juge-Morineau, N., Wijdenes, J. and Amlot, M. (1994) Expression of CD28 and CD40 in human myeloma cells: A comparative study with normal plasma cells. Blood, 84, 2597.
16. Uckun, F. M., Gajil-Peczalska, K., Myers, D. E., Jaszca, W., Haissig, S. and Ledbetter, J. A. (1990) Temporal association of CD40 antigen expression with discrete stages of human B-cell ontogeny and the efficacy of anti-CD40 immunotoxins against clonogenic B-lineage acute lymphoblastic leukemia as well as B-lineage non-Hodgkin's lymphoma cells. Blood, 76, 2449.
17. Stamenkovich, I., Clark, E. A. and Seed, B. (1989) A B-lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas. EMBO J., 8, 1403.
18. Carbone, A., Glogini, A., Gattei, V., Aldinucci, D., Degan, M., De Paoli, P., Zagonel, V. and Pinto, A. (1995) Expression of functional CD40 antigen on Reed-Sternberg cells and Hodgkin's disease cell lines. Blood 85, 780.
19. Smith, G. A., Farrah, T. and Goodwin, R. G. (1994) The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death. Cell 76, 959.
20. Clement, M. V. and Stamenkovic, I. (1994) Fas and tumor necrosis factor receptor-mediated cell death: Similarities and distinctions. J. Exp. Med., 180, 557.
21. Barrett, T. B., Shu, G. and Clark, E. A. (1991) CD40 signaling activates CD11a/CD18 (LFA-1)-mediated adhesion in B cells. J. Immunol., 146, 1722.
22. Rousett, F., Garcia, E., Defrance, T., Peronne, C., Vezzio, N., Hsu, D. H., Kastelein, R., Moore, K. W. and Banchereau, J. (1992) Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc. Natl. Acad. Sci. USA, 89, 1890.
23. Burdin, N., Kooten, C. V., Gailibert, L., Abrams, J. S., Wijdenes, J., Banchereau, J. and Rousset, F. (1995) Endogenous IL-6 and IL-10 contribute to me differentiation of CD40-activated human B lymphocytes. J. Immunol., 154, 2533.
24. Durandy, A., De St. Basile, G., Lisowska-Grospierre, B., Gauchat, J. F., Forveille, M., Kroczek, R. A., Bonnefoy, J. Y. and Fischer, A. (1995) Undetectable CD40 ligand expression on T cells and low B cell responses to CD40 binding agonists in human newborns. J. Immunol., 154, 1560.
25. Inghirami, G., Lederman, S., Yellin, M. J., Chadbum, A., Chess, L. and Knowles, D. M. (1994) Phenotypic and functional characterization of T-BAM (CD40 ligand)+ T-cell non-Hodgkin's lymphoma. Blood 84, 866.
26. Cocks, B. G., de Waal Malefyt, M. R., Galizzi, G. J., de Vries, J. E. and Aversa, G. (1992) IL-13 induces proliferation and differentiation of human B cell activated by the CD40-ligand. Int. Immunol. J., 5, 657.
27. Lederman, S., Yellin, M., Cleary, A., Pernis, A., Inghirami, G., Cohn, L., Covey, L., Lee, J., Rothman, P. and Chess, L. (1994) The T-BAM/CD40L molecule on helper T lymphocytes augments lymphokine-induced B cell immunoglobulin isotype switch recombination and rescues B cells from programmed cell death. J. Immunol., 152, 2163.
28. Foy, T. M., Laman, J. D., Ledbetter, J. A., Aruffo, A., Claasen, E. and Noelle, R. J. (1994) Gp39-CD40 interactions are essential for germinal center formation and the development of B cell memory. J. Exp. Med., 180, 157.
29. Yellin, M. J., Sinning, J., Covey, L. R., Sherman, W., Lee, J. J., Glickman-Nir, E., Sippel, K. C., Rogers, J., Cleary, A. M., Parker, M., Chess, L. and Lederman, S. (1994) T lymphocyte T cell-B cell-activating molecule/CD40-L molecules induce normal B cells or chronic lymphocytic leukemia B cells to express CD80 (B7/BB-1) and enhance their costimulatory activity. J. Immunol., 153, 666.
30. Lederman, S., Yellin, M. J., Inghirami, G., Lee, J. J., Knowles, D. M. and Chess, L. (1992) Molecular interactions mediating T-B lymphocyte collaboration in human lymphoid follicles: Roles of T-BAM (5c8 Ag) and CD40 in contract-dependent help. J. Immunol., 149, 3817.
31. Aruffo, A. M., Farrington, D., Hollenbaugh, D., Li, Z., Milatovich, S., Nonoyama, J., Bajorath, L. S., Grosmarie, S., Stenkamp, M. and Neubauer et al. (1993) The CD40 ligand gp39 is defective in activated T cells from patients with X-linkedhyper-IgM syndrome. Cell, 72, 29.
32. Farrington, M., Grosmaire, L. S., Nonoyama, S., Fischer, S. H., Hollenbaugh, D., Ledbetter, J. A., Noelle, R. J., Aruffo, A. and Ochs, H. D. (1994) CD40 ligand expression is defective in a subset of patients with common variable immunodeficiency. Proc. Natl. Acad. Sci. USA, 91, 1099.
33. Callard, R. D., Smith, S. H., Herbert J., Morgan, G., Padayachee, M., Lederman, S., Chess, L., Kroczek, R. A., Fanslow, W. C. and Armitage, R. J. (1994) CD40 ligand (CD40L) expression and B cell function in agammaglobulinemia with normal or elevated levels of IgM (HIM). J. Immunol., 153, 3295.
34. Durie, F. H., Aruffo, A., Ledbetter, J., Crassi, K. M., Green, W. R., Fast, L. D. and Noelle, R. J. (1994) Antibody to the ligand of CD40, gp 39, blocks the occurrence of the acute and chronic forms of graft-vs-host disease. J. Clin. Invest., 94, 1333.
35. Durie, F. H., Fava, R. A. and Noelle, R. J. (1994) Collagen-induced arthritis as a model of rheumatoid arthritis. Clin. Immunol. Immunopath., 73, 11.
36. Mohan, C., Shi, Y., Laman, J. D. and Datta, S. K. (1995) Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis. J. Immunol., 154, 1470.
37. Jackson, N., Ling, N. R., Ball, J., Bromidge, E, Nathan, P. D. and Franklin, I. M. (1988) An analysis of myeloma plasma cell phenotype using antibodies defined at the IIIrd international workshop on human leucocyte differentiation antigens. Clin. Exp. Immunol., 72, 351.
38. Hamilton, M. S., Ball, J., Bromidge, E. and Franklin, I. M. (1992) Specific antigen expression of human neoplastic plasma cells includes molecules associated with lymphocyte recirculation and adhesion. Br. J. Haematol., 78, 60.
39. Urashima, M., Chauhan, D., Uchiyama, H., Freeman, G. J. and Anderson, K. C. (1995) CD40 ligand triggered interleukin-6 secretion in multiple myeloma. Blood, 85, 1903.
40. Tong, A. W. (1995) Unpublished observations.
41. Kawano, M., Huang, N., Harada, H., Harada, Y., Sakai, A.,Tanaka, H., Iwato, K. and Kuramoto, A. (1993) Identification of immature and mature myeloma cells in the bone marrow of human myelomas. Blood, 82, 564.
42. Harada, H., Kawano, M. M., Huang, N., Harada, Y., Iawato, K., Tanabe, O., Tanaka, H., Sakai, A., Asaoku, H. and Kuramoto, A. (1993) Phenotypic difference of normal plasma cells from mature myeloma cells. Blood, 81, 2658.
43. Karp, J. E., Burke, P. J., Saylor, P. L. and Humphrey, R. L. (1984) Correlation of proliferative and clonogenic tumor cells in multiple myeloma. Cancer Res., 44, 4197.
44. Durie, B. G. M., Salmon, S. E. and Moon, T. E. (1980) Pretreatment tumor mass, cell kinetics, and prognosis in multiple myeloma. Blood, 55, 364.
45. Zhang, X., Childs, B., Siegel, D., Nievsvizky, R., Zelenetz, A. and Michaeli, J. (1994) A novel clonogenic assay for the growth of human myeloma cells in vitro (abstract). Blood, 84 (Suppl I), 175a.
46. Rhodes, E. G., Olive, C. and Flynn, M. P. (1990) A serum-free cultures method for myeloma progenitors in vitro: Proliferative and immunophenotypic characteristics. Exp. Hematol., 18, 79.
47. Kyle, R. A. (1988) Prognostic factors in multiple myeloma. Hematol. Oncol., 6, 125.
48. Borinaga, A. M., Millar, B. C., Bell, J. B., Joffe, J. K., Millar, J. L., Gooding, R., Riches, P. and McElwain, T. J. (1990) Interleukin-6 is a cofactor for the growth of myeloid cells from human bone marrow aspirates but does not affect the clonogencity of myeloma cells in vitro. Br. J. Haematol., 76, 476.
49. Pellat-Deceunynck, C., Amlot, M., Robillard, N. and Bataille, R. (1994) Human myeloma cell growth arrest induced by CD40 stimulation (Abstract). Blood, 84 (Suppl I), 174a.
50. Law, C. L., Wormann, B. and LeBien, T. W. (1990) Analysis of expression and function on normal and leukemic human B cell precursors. Leukemia, 4, 732.
51. Snapper, C. M., Kehry, M. R., Castle, B. E. and Mond, J. J. (1995) Multivalent, but not divalent, antigen receptor cross linkers synergize with CD40 ligand for induction of Ig synthesis and class switching in normal murine B cells. J. Immunol., 154, 1177.
52. Fluckiger, A. C., Rossi, J. F., Bussel, A., Byron, P., Banchereau, J. and Defrance, T. (1992) Responsiveness of chronic lymphocytic leukemia B cells activated via surface Igs or CD40 to B-cell tropic factors. Blood, 80, 3173.
53. Funakoshi, S., Longo, D. L., Beckwith, M., Conley, D. K.,Tsarfaty, G., Tsarfaty, I., Armitage, R. J. Fanslow, W. C., Spriggs, M. K. and Murphy, W. J. (1994) Inhibition of human B-cell lymphoma growth by CD40 stimulation. Blood, 83, 2787.
54. Kaufman, Y., Many, A., Rechavi, G., Mor, O., Biniaminov, M., Rosenthal, E., Levanon, M., Davidsohn, J., Aizman, I., Mark, Z., Brok-Simoni, F. and Ramot, B. (1995) Lymphoma with recurrent cycles of spontaneous remission and relapse - Possible role of apoptosis. New Engl. J. Med., 332, 507.
55. Brenning, G. (1985) The in vitro effect of leucocyte alpha-interferon on human myeloma cells in a semisolid agar culture system. Scand. J. Haematol., 35, 178.
56. Ludwig, C. U., Durie, B. G. M., Salmon, S. E. and Moon, T. E. (1983) Tumor growth stimulation in vitro by interferons. Eur. J. Cancer Clin. Oncol, 19, 1625.
57. Peest, D., Deicher, H. and Coldewey, R. (1990) Mephalan and prednisone vs vinscristinie, BCNU, Adriamycin, melphalan, and dexamethasone induction chemotherapy and interferon maintenance treatment in multiple myeloma. Current results of a multi-center trial. The German myeloma treatment group. Oncologie, 13, 458.
58. Kansas, G. S. and Tedder, T. F. (1991) Transmembrane signals generated through MHC class II, CD19, CD20, CD39 and CD40 antigens induce LFA-1 dependent and independent adhesion in human B cells through a tyrosine-dependent pathway. J. Immunol., 147, 4094.
59. Uckun, F., Schieven, G., Dibirdik, I., Chandan-Langlie, M., TuelAhlgren, I. and Ledbetter, J. A. (1991) Stimulation of protein tyrosine phosphorylation, phosphoinositide turnover, and multiple previously unidentified serine/threonine-specific protein kinases by the pan-B-cell receptor CD40/BP50 at discrete developmental stages of human B-cell ontogeny. J. Biol. Chem., 266, 17478.
60. Ren, C. and Geha, R. (1993) CD40 engagement activates LYN kinase and phosphorylates PLC-γ2, J. Cell Biochem, (Suppl. 17B), 169.
61. Clapham, D. E. (1995) Calcium signaling. Cell. 80, 259.
62. Berberich, I., Shu, G. L. and Clark, E. A. (1994) Cross-linking CD40 on B cells rapidly activates nuclear factor-κB. J. Immunol. 153, 4357.
63. Sha, W. C., Liou, H. C., Tumonanen, E. I. and Baltimore, D. (1995) Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses. Cell. 80, 321.
64. Marshall, C. J. (1995) Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation. Cell, 80, 179.
65. Caligaris-Cappio, F., Bergui, L., Gregoretti, M. G., Gaidano, G., Gaboli, M., Schena, M., Zallone, A. and Marchisio, P. C. (1991) Role of bone marrow stromal cells in the growth of human multiple myeloma. Blood, 77, 2688.
66. Mellstedt, H., Holm, G., Pettersson, D. and Peest, D. (1982) Idiotype-bearing lymphoid cells in plasma cell neoplasia. Clin. Haematol., 11, 65.
67. Jensen, G. S., Mant, M. J., Belch, A. J., Berenson, J. R., Reuther, B. A. and Pilarski, L. M. (1991) Selective expression of CD45 isoforms defines CALLA + monoclonal B lineage cells in peripheral blood from myeloma patients as late stage B cells. Blood, 78, 711.
68. Bergsagel, P. L., Belch, A. R. and Pilarski, L. M. (1994) The blood B cells and bone marrow plasma cells in a patient with multiple myeloma include cells with the same N-ras mutation (Abstract). Blood, 84 (Suppl I), 524a.
69. DeGrassi, A., Hibert, D. M., Rudikoff, S., Anderson, A. O., Potter, M. and Coon, H. G. (1993) In vitro culture of primary plasmacytomas requires stromal cell feeder layers. Proc. Natl Acad. Sci. USA, 90, 2060.
70. Chabannon, C. and Mannoni, P. (1994) Role of growth factors in the control of leukemic cell proliferation. Leukemia Lymphoma, 13 (Suppl I), 35.
71. Nagata, K., Tanaka, Y., Oda, S., Yamashita, U. and Eto, S. (1991) Interleukin 1 autocrine growth system in human multiple myeloma. Jpn. J. Clin. Oncol., 21, 22.
72. Herrman, F., Andreeff, M., Gruss, H. J., Brach, M. A., Lubbert, M. and Mertelsman, R. (1991) Interleukin-4 inhibits growth of multiple myelomas by suppressing interleukin-6 expression. Blood, 78, 2070.
73. Ameglio, F., Alvino, S., Trento, E., Marcucci, M., Pimpinelli, F., Tong, A. W., Gandolf, G. M. and Greco, C. (1995) Serum interleukin-10 levels in patients affected with multiple myeloma: Correlation with the monoclonal component and disease progression. Int. J. Oncol., 6, 1189.
74. Palumbo, A., Battaglio, S., Napoli, P., Omede, P., Fusaro, A., Bruno, B., Boccadoro, M. and Pileri, A. (1994) Recombinant interferon-gamma inhibits the in vitro proliferation of human myeloma cells. Br. J. Haematol., 86, 726.
75. Sonneveld, P., Schoester, M. and de Leeuw, K. (1991) In vitro Ig-synthesis and proliferative activity in multiple myeloma are stimulated by different growth factors. Br. J. Haematol., 79, 589.
76. Valle, A., Zuber, C. E., Defrance, T., Djossou, O., de Rie, M. and Banchereau, J. (1989) Activation of human B lymphocytes through CD40 and interleukin 4. Eur. J. Immunol., 19, 1463.
77. Levy, Y., Labaume, S., Gendron, M. C. and Brouet, J. C. (1994) Modulation of spontaneous B-cell differentiations in macroglobulinemia by retinoic acid. Blood, 83, 206.
78. Ballester, O. F., Moscinski, L. C., Lyman, G. H., Chaney, J. V., Saba, H. I., Spiers, A. S. D. and Klein, C. (1994) High levels of interleukin-6 are associated with low tumor burden and low growth fraction in multiple myeloma. Blood, 83, 1903.
79. Lokhorst, H. M., Lamme, T., de Smet, M., Klein, S., de Weger, R. A., van Oers, R. and Bloem, A. C. (1994) Primary tumor cells of myeloma patients induce interleukin-6 secretion in long-term bone marrow cultures. Blood, 84, 2269.
80. Uchiyama, H., Barut, B. A., Mohrbacher, A. F., Chauhan, D. and Anderson, K. C. (1993) Adhesion of human myeloma-derived cell lines to bone marrow stromal cells stimulates interleukin-6 secretion. Blood, 82, 3712.
81. Hata, H., Ziao, H., Petrucci, M. T., Woodliff, J., Chang, R. and Epstein, J. (1993) Interleukin-6 gene expression in multiple myeloma: A characteristic of immature tumor cells. Blood, 81, 3357.
82. Tong, A. W., Huang, Y. W., Ghetie, V., Nemunaitis, J., Pineiro, L., Vitetta, E. and Stone, M. J. (1994) Enhancement of anti-CD54 immunotoxin cytotoxicity to human myeloma cells by cyclosporin drugs (abstract). Blood, 84 (Suppl I), 170a.
83. Huang, Y. M., Richardson, J. A. and Vitetta, E. S. (1995) Anti-CD54 (ICAM-1) has antitumor activity in SCID mice with human myeloma cells. Cancer Res., 55, 610.